Liver cancer, particularly hepatocellular carcinoma (HCC), is a significant global health concern, ranking as the sixth most common cancer and the fourth leading cause of cancer-related deaths worldwide. Early detection improves treatment outcomes and patient survival. Imaging techniques, especially CT scans, play an important role in liver cancer diagnosis.
CT scans provide detailed, noninvasive visualization of the liver and surrounding structures. They offer high diagnostic accuracy for detecting liver tumors and lesions. CT scans are particularly valuable for screening high-risk individuals, aiding in cancer staging, treatment planning, and guiding procedures like biopsies.
A computed tomography (CT) scan is a diagnostic imaging procedure that uses X-ray technology and computer processing to create detailed cross-sectional images of the body1. It produces more detailed images than standard X-rays, allowing healthcare professionals to visualize internal structures such as bones, muscles, organs, and blood vessels.
CT scans are advanced medical imaging techniques that use X-rays and computer processing to create detailed cross-sectional images of the body. The technology involves a rotating X-ray tube and detectors that measure X-ray attenuation through different tissues2. These measurements are then processed using tomographic reconstruction algorithms to produce virtual “slices” of the body.
The CT machine consists of a motorized table that moves the patient through a circular opening called the gantry3. Inside the gantry, an X-ray source and detector assembly rotate around the patient, typically completing a rotation in less than a second. As the X-rays pass through the body, detectors register the radiation that emerges, creating snapshots from various angles. The computer then reconstructs these snapshots into cross-sectional images or slices of the internal organs and tissues.
CT scans play an important role in detecting liver cancer by providing detailed, cross-sectional images of the liver and surrounding tissues. These scans use X-rays and computer processing to create high-resolution images that can reveal tumors, lesions, and other abnormalities within the liver.
A contrast agent is typically injected into the patient’s vein to visualize all the structures in the liver. This iodine-based dye enhances the visibility of blood vessels and tissues, making tumors more apparent4. Radiologists can observe how it moves through the liver’s blood vessels, highlighting abnormal areas that might indicate cancer.
Signs of liver cancer on a CT scan might include:
Contrast-enhanced CT scans significantly improve liver cancer detection. Dynamic multiphase contrast-enhanced CT is considered to be a standard for diagnosing HCC9. This technique involves taking multiple images at different time points after contrast injection10.
Arterial phase: Captures early enhancement of hypervascular tumors.
Portal venous phase: Shows contrast distribution throughout the liver.
Delayed phase: Can reveal washout characteristics of malignant lesions.
These phases allow radiologists to observe the dynamic behavior of liver lesions, which is crucial for accurate diagnosis. The American College of Radiology's LI-RADS (Liver Imaging Reporting and Data System) classification uses these imaging characteristics to categorize liver lesions and determine their likelihood of being HCC11.
While CT scans are highly effective in detecting liver cancer, very small lesions (less than 1 cm) may be missed12. Therefore, CT scans are often used in conjunction with other imaging modalities like MRI, ultrasound, and blood tests for comprehensive liver cancer diagnosis and staging13.
Early detection of liver cancer significantly improves patient outcomes and survival rates. Patients with very early-stage hepatocellular carcinoma (HCC) can achieve 5-year survival rates of 70 - 80 percent after treatments like surgical resection or liver transplantation14,15. This is a stark contrast to the overall 5-year net survival rate for liver cancer, which is only about 22 percent16.
CT scans play an important role in the early detection and accurate staging of liver cancer. They have a sensitivity of 77.5 percent and a specificity of 91.3 percent for detecting HCCs of any size and stage17. CT is highly accurate in identifying the number of lesions, affected liver segments, regional lymph node involvement, and vascular tumor invasion18. This precise staging information allows doctors to determine the best treatment approach.
CT scans can also detect small tumors. For tumors between 10-20 mm, CT scans have a sensitivity of 84 percent, allowing medical practitioners to catch liver cancers at their earliest stages. CT surveillance is associated with significant improvements in early tumor detection, providing curative therapy, and overall survival in patients with cirrhosis14.
You might be recommended to get a CT scan if you have specific risk factors or symptoms that suggest a higher likelihood of developing liver cancer.
Symptoms that could prompt a CT scan include25:
It’s important to note that early-stage liver cancer often doesn’t cause symptoms, which is why regular screening for high-risk individuals is imperative.
If you are a high-risk individual, there are several recommendations you should consider26:
The cost of a CT scan for liver cancer in the United States can vary but typically ranges from $464 to $1,06127,28. However, the total cost of liver cancer screening, which may include multiple tests over time, can be much higher. The average lifetime cost of liver cancer screening is estimated to be between $6,400 and $8,600 per person.
Insurance coverage for CT scans used for liver cancer detection is generally good. Medicare usually covers most cancer screening tests, including CT scans for liver cancer, often with little to no out-of-pocket cost29. Private insurance plans are required by the Affordable Care Act (ACA) to cover certain cancer screening tests, though coverage may vary depending on the specific plan. For those with Medicare Advantage plans, CT scans are typically covered, but costs may vary depending on the specific plan30.
Ezra offers comprehensive full-body MRI scans that cover multiple organs, including the liver. Their advanced scanning technology can screen for potential cancer and over 500 conditions in up to 13 organs. Ezra accepts FSA/HSA dollars and provides flexible payment plans.
Ionizing radiation from medical imaging, particularly CT scans, poses potential health risks by damaging living tissues at the atomic level. This damage can potentially increase cancer risk over time31. Low-dose CT (LDCT) scans have been developed to address these concerns as a safer alternative for routine screenings.
LDCT scans use substantially less radiation than standard CT scans, making them more suitable for frequently monitoring conditions. A standard CT scan of the abdomen, which includes the liver, typically delivers an effective dose of about 5-10 mSv (millisieverts). A CT scan of the abdomen and pelvis can deliver up to 15.4 mSv, which is equivalent to about five years of background radiation exposure32.
In contrast, LDCT scans use significantly less radiation. An LDCT of the chest delivers about 1.4 mSv, equivalent to about 6 months of background radiation33.
You might need to fast for several hours before your appointment for a liver CT scan procedure34. Clear fluids and medications are usually allowed32. Diabetic patients can have a light snack if necessary. You should wear comfortable, loose-fitting clothing to your appointment and will likely be given a hospital gown for the scan. You should remove any metal items, including jewelry, from the scanned area.
For liver CT scans, you might need a contrast-enhanced scan. An IV line may be placed, or you might be given an oral contrast to drink35. You should inform your healthcare provider about allergies, especially to iodine or contrast materials.
You should also inform your doctor if you are or might be pregnant. Also, disclose any medical conditions, recent illnesses, or medications you take. For example, if you’re taking metformin for diabetes, you may need to temporarily stop this medication36.
CT scans play a vital role in detecting liver cancer at an early stage, significantly improving treatment options and patient outcomes. Their ability to generate detailed, high-resolution images aids in identifying tumors and lesions, making them indispensable for accurate staging. Contrast agents enhance visibility, ensuring even subtle abnormalities are detected. For individuals in high-risk groups or experiencing potential symptoms, consulting a healthcare provider is essential for timely screening and diagnosis. Early detection through CT scanning can improve overall survival and is an essential part of the liver cancer diagnosis process, alongside MRI and ultrasound.
If you want to be proactive about your health, why not book an Ezra Full-Body Plus? We combine MRI with LDCT to catch potential cancer earlier, leveraging AI through the screening process to make it more efficient, affordable, and faster.
1. Definition of CT scan - NCI Dictionary of Cancer Terms - NCI. February 2, 2011. Accessed December 9, 2024. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ct-scan
2. CT scan - Mayo Clinic. Accessed December 9, 2024. https://www.mayoclinic.org/tests-procedures/ct-scan/about/pac-20393675
3. Computed Tomography (CT). National Institute of Biomedical Imaging and Bioengineering. Accessed December 9, 2024. https://www.nibib.nih.gov/science-education/science-topics/computed-tomography-ct
4. Liver Cancer Screening - NCI. May 19, 2022. Accessed February 7, 2025. https://www.cancer.gov/types/liver/what-is-liver-cancer/screening
5. Kamaya A, Maturen KE, Tye GA, Liu YI, Parti NN, Desser TS. Hypervascular Liver Lesions. Seminars in Ultrasound, CT and MRI. 2009;30(5):387-407. doi:10.1053/j.sult.2009.06.001
6. Fang C, Anupindi SA, Back SJ, et al. Contrast-enhanced ultrasound of benign and malignant liver lesions in children. Pediatr Radiol. 2021;51(12):2181-2197. doi:10.1007/s00247-021-04976-2
7. Stevens WR, Gulino SP, Batts KP, Stephens DH, Johnson CD. Mosaic pattern of hepatocellular carcinoma: histologic basis for a characteristic CT appearance. J Comput Assist Tomogr. 1996;20(3):337-342. doi:10.1097/00004728-199605000-00001
8. Kojiro M. ‘Nodule-in-Nodule’ Appearance in Hepatocellular Carcinoma: Its Significance as a Morphologic Marker of Dedifferentiation. Intervirology. 2004;47(3-5):179-183. doi:10.1159/000078470
9. Choi YR, Chung JW, Yu MH, Lee M, Kim JH. Diagnostic accuracy of contrast-enhanced dynamic CT for small hypervascular hepatocellular carcinoma and assessment of dynamic enhancement patterns: Results of two-year follow-up using cone-beam CT hepatic arteriography. PLoS One. 2018;13(9):e0203940. doi:10.1371/journal.pone.0203940
10. Hennedige T, Kundapur Venkatesh S. Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring. Cancer Imaging. 2013;12(3):530-547. doi:10.1102/1470-7330.2012.0044
11. Chernyak V, Fowler KJ, Kamaya A, et al. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. Radiology. 2018;289(3):816-830. doi:10.1148/radiol.2018181494
12. Mittal R, Kowal C, Starzl T, et al. Accuracy of Computerized Tomography in Determining Hepatic Tumor Size in Patients Receiving Liver Transplantation or Resection. J Clin Oncol. 1984;2(6):637-642.
13. Liver Cancer Diagnosis - NCI. May 19, 2022. Accessed February 7, 2025. https://www.cancer.gov/types/liver/what-is-liver-cancer/diagnosis
14. Singal AG, Pillai A, Tiro J. Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis. PLoS Med. 2014;11(4):e1001624. doi:10.1371/journal.pmed.1001624
15. Yang JD. Detect or not to detect very early stage hepatocellular carcinoma? The western perspective. Clin Mol Hepatol. 2019;25(4):335-343. doi:10.3350/cmh.2019.0010
16. cancer CCS/ S canadienne du. Survival statistics for liver cancer. Canadian Cancer Society. September 2019. Accessed February 7, 2025. https://cancer.ca/en/cancer-information/cancer-types/liver/prognosis-and-survival/survival-statistics
17. How accurate are computerised tomography (CT) scans for detecting liver cancer? doi:10.1002/14651858.CD013362.pub2
18. Szklaruk J, Silverman PM, Charnsangavej C. Imaging in the Diagnosis, Staging, Treatment, and Surveillance of Hepatocellular Carcinoma. American Journal of Roentgenology. 2003;180(2):441-454. doi:10.2214/ajr.180.2.1800441
19. Sharma A, Nagalli S. Chronic Liver Disease. In: StatPearls. StatPearls Publishing; 2025. Accessed February 7, 2025. http://www.ncbi.nlm.nih.gov/books/NBK554597/
20. Sachar Y, Brahmania M, Dhanasekaran R, Congly SE. Screening for Hepatocellular Carcinoma in Patients with Hepatitis B. Viruses. 2021;13(7):1318. doi:10.3390/v13071318
21. Chuang SC, Vecchia CL, Boffetta P. Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Letters. 2009;286(1):9-14. doi:10.1016/j.canlet.2008.10.040
22. Chang ET, Keegan THM, Gomez SL, et al. The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004. Cancer. 2007;109(10):2100-2108. doi:10.1002/cncr.22642
23. Muhimpundu S, Conway RBN, Warren Andersen S, et al. Racial Differences in Hepatocellular Carcinoma Incidence and Risk Factors among a Low Socioeconomic Population. Cancers (Basel). 2021;13(15):3710. doi:10.3390/cancers13153710
24. Liver Cancer Risk Factors | Risk of Liver Cancer. Accessed February 7, 2025. https://www.cancer.org/cancer/types/liver-cancer/causes-risks-prevention/risk-factors.html
25. Symptoms of liver cancer. nhs.uk. July 6, 2023. Accessed February 7, 2025. https://www.nhs.uk/conditions/liver-cancer/symptoms/
26. Who Should Be Screened? » Hepatitis B Foundation. Accessed February 7, 2025. https://www.hepb.org/research-and-programs/liver/screening-for-liver-cancer/who-should-be-screened/
27. Samur S, Rustgi VK, Parikh ND, et al. Cost of Liver Cancer Screening in Patients with Cirrhosis. Value in Health. 2023;26(6):S152. doi:10.1016/j.jval.2023.03.2487
28. Schnitzer ML, von Münchhausen N, Biechele G, et al. Cost-effectiveness analysis of MRI, CE-CT and 18F-FDG PET/CT for detecting colorectal liver metastases eligible for hepatic resection. Front Oncol. 2023;13:1161738. doi:10.3389/fonc.2023.1161738
29. Costs and Insurance Coverage for Cancer Screening. Accessed January 14, 2025. https://www.cancer.org/cancer/screening/cancer-screening-costs-insurance-coverage.html
30. Does Medicare cover liver cancer care? Costs and more. November 30, 2020. Accessed February 7, 2025. https://www.medicalnewstoday.com/articles/does-medicare-cover-liver-cancer
31. Computed Tomography (CT) Scans and Cancer Fact Sheet - NCI. January 3, 2024. Accessed July 16, 2024. https://www.cancer.gov/about-cancer/diagnosis-staging/ct-scans-fact-sheet
32. Radiology (ACR) RS of NA (RSNA) and AC of. Radiation Dose. Radiologyinfo.org. Accessed December 12, 2024. https://www.radiologyinfo.org/en/info/safety-xray
33. Low-dose CT Scan: LDCT for Lung Cancer Screening. City of Hope. January 6, 2021. Accessed January 7, 2025. https://www.cancercenter.com/cancer-types/lung-cancer/diagnosis-and-detection/low-dose-ct-scan
34. CT scan. nhs.uk. October 18, 2017. Accessed December 9, 2024. https://www.nhs.uk/conditions/ct-scan/
35. Rogers DC, Tadi P. Intravenous Contrast. In: StatPearls. StatPearls Publishing; 2024. Accessed December 9, 2024. http://www.ncbi.nlm.nih.gov/books/NBK557794/
36. Imperial College Healthcare. Having a CT Scan. Having a CT Scan - Information for Patients. 2019. Accessed December 9, 2024. https://www.imperial.nhs.uk/-/media/website/patient-information-leaflets/imaging/having-a-ct-scan.pdf?rev=a4168516b0374dbf9ea6214e676c0d79&sc_lang=en